Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Intravitreal administration"”.
-
Techniques for screening protein-protein interactions to guide viscosity prediction during developability assessments
… significant challenges for subcutaneous and intravitreal administration and overall developability. This study investigated various approaches to understanding high viscosity in concentrated mAb formulations, focusing on evaluations of protein-protein interactions. First, dynamic light …
-
Siponimod as a novel therapeutic for ocular neovascular diseases: biological characterization and development of controlled release systems
… are costly macromolecules requiring frequent intravitreal administration and are associated with various adverse effects and high treatment resistance rates. Consequently, identifying small molecular weight angiogenesis inhibitors with alternative mechanisms of action and developing sustained, …
-
The role of VIP family members in diabetic retinopathy
… endothelial growth factor (VEGF). To date, intravitreal injection of agents directed against VEGF represents the elective DR therapy. However, they counteract efficaciently ocular neovascularization only in 50% of treated patients, suggesting that other pathogenic events may play an …
-
Non-viral gemini surfactant-phospholipid nanoparticles for topical gene delivery to the retina
… mediated by viral gene carriers and invasive administration methods. Non-viral gene delivery systems offer a safe and increasingly efficient alternative to deliver therapeutic genes to the retina. An example of these systems is gemini-phospholipid nanoparticles (GL-NPs), which have been …
-
Design and Evaluation of Targeted mRNA Delivery Systems to the Retina
… lipid nanoparticle (LNP) system for mRNA for intravitreal (IVT) delivery in the eye using a second-generation parent 18-7NH-18 gemini surfactant (GS) and three derived cell-adhesive-peptide (CAP p1, p3 and p5) conjugated GSs: 18-7Np1-18, 18-7Np3-18, and 18-7Np5-18, along with other lipids. The …
-
Fomulation and Delivery of Drugs for Macular Edema and Retinoblastoma; Synthesis and In Vitro Characterization of Doxorubicin Loaded Surface Modified Nanoparticles Using PLGA-PEG-PLGA Polymer
… retina. Recent work has explored the systemic/intravitreal administration of topotecan, etoposide, carboplatin and vincristine for the treatment of RB. However, the current therapy is associated with non-specific toxicity and patient non-compliance. An attempt was made to develop and evaluate a …
-
Εξωαγγειακές προσεγγίσεις για τη λύση του θρόμβου σε απόφραξη φλέβας του αμφιβληστροειδή: πειραματική και κλινική μελέτη
… with extravascular – nearby the occluded vessel, administration of recombinant tissue plasminogen activator (rt-PA), in a clinical and experimental case series of retinal vein thrombosis. MATERIAL – METHODS - RESULTS Clinical Study 3 patients with recent central retinal vein occlusion and 3 …
-
In vivo μελέτη της νευροπροστατευτικής δράσης της σωματοστατίνης στην αμφιβληστροειδική διεγερτοτοξικότητα
… employing the excitatory amino acid AMPA. The intravitreal administration of AMPA (42nmol per rat eye) resulted in a loss of retinal neurons such as cholinergic amacrine, bNOS expressing amacrine and horizontal cells, 24 hours after its administration. An increase in apoptosis was also observed …
-
Disease characterization and pre-clinical testing in canine models of the neuronal ceroid lipofuscinoses
… of delivering functional TPP1 to the retina: (1) intravitreal enzyme replacement therapy, (2) ex vivo cell-mediated gene therapy and (3) in vivo intravitreal gene therapy. Additionally, we tested an ex vivo cell-mediated gene therapy approach to deliver TPP1 to the central nervous system as an …
-
Oral Administration Of Alpha-Cyclodextrin Corrects Diabetes Induced Retinopathy And Bone Marrow Pathology By Modulation Of The Gut-Retina Axis.
… levels in diabetic conditions. Systemic administration of SIRT1 to diabetic mice led to attenuated inflammation and diminished cellular apoptosis. Remarkably, targeted intravitreal administration of SIRT1 to the retina of diabetic mice resulted in reduced retinal inflammation, cellular …
-
Τρόπος δράσης και θεραπευτικό όφελος της ενδοϋαλοειδικής χορήγησης μεσεγχυματικών κυττάρων λιπώδους ιστού και νανοφορέων anti-VEGF σε επαγόμενο ζωικό μοντέλο φλεβικής απόφραξης του αμφιβληστροειδούς
… has been applied to induce RVO following intravitreal administration to rabbits. The aim of the present study is to determine the effect of adipose derived-MSCs (ASCs) combination with nanocarriers of anti-VEGF in a PD0325901-mediated induced animal model of RVO.In an in vitro approach, …
-
Μελέτη της φαρμακοκινητικής και της ενδεχόμενης αμφιβληστροειδικής τοξικότητας πρωτότυπων συνθετικών νευροστεροειδών μορίων με νευροπροστατευτική δράση
… of BNN27, both after systemic and local administration, in the blood, but also in the target- tissue, the posterior segment of the eye (vitreous and retina), as well as to assess for any retinal toxicity after local administration. After the initial spectroscopic characterisation of the …
-
Ιστολογική μελέτη των επιδράσεων της ενδοϋαλοειδικής χορήγησης αντιμυκητιακών φαρμάκων στον αμφιβληστροειδή: πειραματική μελέτη
… options available both systemically and intravitrealy. In the past, Amphotericin B (AMB) was the only antifungal agent approved for intravitreal administration. However, amphotericin B has been reduced due to significant nephrotoxicity and relatively low intraocular penetration, retinal …
-
Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους
… of Avastin, in the left eye and serum, after intravitreal injection of 1.25 mg/0.05 ml Avastin in the right eye in rabbits. Avastin is a very important drug in Ophthalmology today. The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 ml Avastin at day 0. Both eyes of four …